rs61749712

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001110792.2(MECP2):​c.621C>T​(p.Gly207Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,209,993 control chromosomes in the GnomAD database, including 1 homozygotes. There are 70 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G207G) has been classified as Likely benign. The gene MECP2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.00011 ( 1 hom. 70 hem. )

Consequence

MECP2
NM_001110792.2 synonymous

Scores

1
5
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.85

Publications

1 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, ClinGen
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001110792.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028884292).
BP6
Variant X-154031243-G-A is Benign according to our data. Variant chrX-154031243-G-A is described in ClinVar as Benign. ClinVar VariationId is 143626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.85 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000537 (6/111743) while in subpopulation SAS AF = 0.00189 (5/2643). AF 95% confidence interval is 0.000745. There are 0 homozygotes in GnomAd4. There are 0 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 XL,Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.621C>Tp.Gly207Gly
synonymous
Exon 3 of 3NP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.585C>Tp.Gly195Gly
synonymous
Exon 4 of 4NP_004983.1D3YJ43
MECP2
NM_001316337.2
c.306C>Tp.Gly102Gly
synonymous
Exon 5 of 5NP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.621C>Tp.Gly207Gly
synonymous
Exon 3 of 3ENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.585C>Tp.Gly195Gly
synonymous
Exon 4 of 4ENSP00000301948.6P51608-1
MECP2
ENST00000407218.5
TSL:5
c.512C>Tp.Ala171Val
missense
Exon 4 of 4ENSP00000384865.2B5MCB4

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111689
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00189
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000169
AC:
31
AN:
183365
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000114
AC:
125
AN:
1098250
Hom.:
1
Cov.:
34
AF XY:
0.000193
AC XY:
70
AN XY:
363610
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00199
AC:
108
AN:
54148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40531
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000950
AC:
8
AN:
842137
Other (OTH)
AF:
0.000195
AC:
9
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000537
AC:
6
AN:
111743
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33945
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30699
American (AMR)
AF:
0.00
AC:
0
AN:
10678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3536
South Asian (SAS)
AF:
0.00189
AC:
5
AN:
2643
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6082
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
53038
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000267
Hom.:
0
Bravo
AF:
0.0000264
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
MECP2-related disorder (1)
-
-
1
Rett syndrome (1)
-
-
1
Severe neonatal-onset encephalopathy with microcephaly (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
8.1
DANN
Uncertain
0.98
DEOGEN2
Benign
0.071
T
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.54
T
M_CAP
Pathogenic
0.61
D
MetaRNN
Benign
0.029
T
MetaSVM
Uncertain
0.65
D
PhyloP100
2.8
REVEL
Uncertain
0.34
Sift4G
Uncertain
0.034
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61749712;
hg19: chrX-153296694;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.